The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 23, 2024

Filed:

Oct. 13, 2020
Applicant:

Athenex HK Innovative Limited, Hong Kong, CN;

Inventors:

Denise S. B. Chan, Hong Kong, CN;

Ming Tsung Lee, Hong Kong, CN;

Weng Li Yoon, Hong Kong, CN;

Johnson Yiu-Nam Lau, Newport Beach, CA (US);

Assignee:

Health Hope Pharma Ltd, Kowloon, HK;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/337 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 9/48 (2006.01); A61K 31/4725 (2006.01); A61K 45/06 (2006.01); A61K 47/12 (2006.01); A61K 47/14 (2017.01); A61K 47/26 (2006.01); A61K 47/44 (2017.01);
U.S. Cl.
CPC ...
A61K 31/337 (2013.01); A61K 9/0053 (2013.01); A61K 9/1075 (2013.01); A61K 9/4858 (2013.01); A61K 31/4725 (2013.01); A61K 45/06 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/26 (2013.01); A61K 47/44 (2013.01);
Abstract

A pharmaceutical composition comprises a taxane (e.g., paclitaxel, docetaxel, cabazitaxel, larotaxel, ortataxel, and/or tesetaxel) in a mixture of first and second surfactants. The absorption of the taxane is increased from the pharmaceutical composition is greater than the sum of the absorption of docetaxel from either the first or the second surfactant. The increase in absorption is especially enhanced when the ratio of the first surfactant to the second surfactant in the pharmaceutical composition is between 60:40 and 85:15 by weight, and the total surfactant weight does not exceed 98% of the total weight. Polysorbate 80, polysorbate 20, and caprylocaproyl polyoxylglycerides serve as suitable first surfactants, and polysorbate 80 or polyethyoxylated castor oil serve as suitable second surfactants. The stability of the pharmaceutical composition may be enhanced by further including a stabilizer (e.g., citric acid and/or ascorbic acid).


Find Patent Forward Citations

Loading…